SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-026924
Filing Date
2022-11-10
Accepted
2022-11-10 16:30:22
Documents
14
Period of Report
2022-11-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20221109_8k.htm   iXBRL 8-K 27211
2 EXHIBIT 99.1 ex_445714.htm EX-99.1 43842
  Complete submission text file 0001437749-22-026924.txt   214409

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20221107.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20221107_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20221107_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20221107_pre.xml EX-101.PRE 11689
8 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20221109_8k_htm.xml XML 2573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 221377753
SIC: 2834 Pharmaceutical Preparations